Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | Senior V. P., Operations | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEMAITRE VASCULAR INC
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 11.2033 |
Reported balance
After 2026-09-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-03 · Grant · Acquired 0.9556 · Balance 11.2033 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 11.1949 |
Reported balance
After 2026-09-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-03 · Grant · Acquired 0.9556 · Balance 11.1949 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 13.5014 |
Reported balance
After 2026-09-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-03 · Grant · Acquired 1.6351 · Balance 13.5014 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 14.774 |
Reported balance
After 2026-09-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-03 · Grant · Acquired 1.9599 · Balance 14.774 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 12.2651 |
Reported balance
After 2026-09-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-03 · Grant · Acquired 2.1927 · Balance 12.2651 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 13.0157 |
Reported balance
After 2026-09-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-03 · Grant · Acquired 2.4831 · Balance 13.0157 F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 9.4928 |
Reported balance
After 2026-09-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-03 · Grant · Acquired 3.6735 · Balance 9.4928 F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 20, 2024 Filed Dec 26, 2024 21:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 55 | $92.12 | $5,066.60 |
DisclosureSEC source: 0001437749-24-038383 · rdgdoc.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,074 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 20, 2019. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 20, 2024 Filed Dec 26, 2024 21:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 9 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-038383 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,129 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 22:53 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037496 · rdgdoc.xml · derivative · entry 9 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11.0974 Underlying: Common Stock · 5 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · shares: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 22:53 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037496 · rdgdoc.xml · derivative · entry 8 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11.1058 Underlying: Common Stock · 5 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 22:53 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 89 | $100.28 | $8,924.92 |
DisclosureSEC source: 0001437749-24-037496 · rdgdoc.xml · nonDerivative · entry 6 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,120 F4 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units (PSU) awarded to the reporting person on December 12, 2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 22:53 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 89 | $100.28 | $8,924.92 |
DisclosureSEC source: 0001437749-24-037496 · rdgdoc.xml · nonDerivative · entry 5 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,209 F3 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 12, 2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 22:53 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037496 · rdgdoc.xml · nonDerivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 22:53 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037496 · rdgdoc.xml · nonDerivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 22:53 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 7 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037496 · rdgdoc.xml · derivative · entry 7 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11.5503 Underlying: Common Stock · 7 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 22:53 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 88 | $101.00 | $8,888.00 |
DisclosureSEC source: 0001437749-24-037496 · rdgdoc.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,288 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 11, 2021. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 22:53 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 7 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037496 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,376 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 09, 2024 Filed Dec 12, 2024 02:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037271 · rdgdoc.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.0589 Underlying: Common Stock · 2 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 09, 2024 Filed Dec 12, 2024 02:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 77 | $101.12 | $7,786.24 |
DisclosureSEC source: 0001437749-24-037271 · rdgdoc.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,369 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 8, 2023. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 09, 2024 Filed Dec 12, 2024 02:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037271 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,446 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 22:16 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 5,321 | $0.00 Strike: $101.12 | $0.00 |
DisclosureSEC source: 0001437749-24-037132 · rdgdoc.xml · derivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,321 Underlying: Common Stock · 5,321 shares Expires 2031-12-06 F2 · derivative.exercise_date: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 22:16 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 927 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037132 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,444 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining three years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date. Read SEC document |
| December 05, 2024 Filed Dec 10, 2024 00:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.6167 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037036 · rdgdoc.xml · derivative · entry 6 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.0589 Underlying: Common Stock · 1.6167 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 05, 2024 Filed Dec 10, 2024 00:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.4187 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037036 · rdgdoc.xml · derivative · entry 5 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16.0974 Underlying: Common Stock · 1.4187 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 05, 2024 Filed Dec 10, 2024 00:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.4187 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037036 · rdgdoc.xml · derivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16.1058 Underlying: Common Stock · 1.4187 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 05, 2024 Filed Dec 10, 2024 00:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.9276 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037036 · rdgdoc.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18.5503 Underlying: Common Stock · 0.9276 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 05, 2024 Filed Dec 10, 2024 00:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.2546 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037036 · rdgdoc.xml · derivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11.6279 Underlying: Common Stock · 0.2546 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 05, 2024 Filed Dec 10, 2024 00:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.2673 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037036 · rdgdoc.xml · derivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.9728 Underlying: Common Stock · 0.2673 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 22:07 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-036709 · rdgdoc.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11.3733 Underlying: Common Stock · 2 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 22:07 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 46 | $105.47 | $4,851.62 |
DisclosureSEC source: 0001437749-24-036709 · rdgdoc.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,517 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 2, 2020. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 22:07 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-036709 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| August 29, 2024 Filed Sep 3, 2024 23:53 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.8658 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-028308 · rdgdoc.xml · derivative · entry 6 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.4422 Underlying: Common Stock · 1.8658 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 29, 2024 Filed Sep 3, 2024 23:53 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.6377 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-028308 · rdgdoc.xml · derivative · entry 5 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14.6787 Underlying: Common Stock · 1.6377 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 29, 2024 Filed Sep 3, 2024 23:53 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.6377 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-028308 · rdgdoc.xml · derivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14.6871 Underlying: Common Stock · 1.6377 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 29, 2024 Filed Sep 3, 2024 23:53 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.0706 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-028308 · rdgdoc.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17.6227 Underlying: Common Stock · 1.0706 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 29, 2024 Filed Sep 3, 2024 23:53 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.5764 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-028308 · rdgdoc.xml · derivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13.3733 Underlying: Common Stock · 0.5764 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 29, 2024 Filed Sep 3, 2024 23:53 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.3084 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-028308 · rdgdoc.xml · derivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.7055 Underlying: Common Stock · 0.3084 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:37 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 182 | $0.00 Strike: $31.30 | $0.00 |
DisclosureSEC source: 0001437749-24-025202 · rdgdoc.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 182 shares Expires 2024-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:37 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 182 | $81.82 | $14,891.24 |
DisclosureSEC source: 0001437749-24-025202 · rdgdoc.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,561 Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:37 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 182 | $31.30 | $5,696.60 |
DisclosureSEC source: 0001437749-24-025202 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 21:06 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.0952 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019071 · rdgdoc.xml · derivative · entry 6 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.5764 Underlying: Common Stock · 2.0952 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 21:06 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.8387 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019071 · rdgdoc.xml · derivative · entry 5 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13.041 Underlying: Common Stock · 1.8387 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 21:06 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.8387 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019071 · rdgdoc.xml · derivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13.0494 Underlying: Common Stock · 1.8387 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 21:06 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.2018 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019071 · rdgdoc.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16.5521 Underlying: Common Stock · 1.2018 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 21:06 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.647 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019071 · rdgdoc.xml · derivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12.7969 Underlying: Common Stock · 0.647 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 21:06 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.346 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019071 · rdgdoc.xml · derivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.3971 Underlying: Common Stock · 0.346 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:26 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.4812 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010429 · rdgdoc.xml · derivative · entry 6 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.4812 Underlying: Common Stock · 2.4812 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:26 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.1771 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010429 · rdgdoc.xml · derivative · entry 5 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11.2023 Underlying: Common Stock · 2.1771 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:26 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.1771 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010429 · rdgdoc.xml · derivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11.2107 Underlying: Common Stock · 2.1771 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:26 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.4234 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010429 · rdgdoc.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15.3503 Underlying: Common Stock · 1.4234 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:26 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.7664 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010429 · rdgdoc.xml · derivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12.1499 Underlying: Common Stock · 0.7664 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:26 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.41 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010429 · rdgdoc.xml · derivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.0511 Underlying: Common Stock · 0.41 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 20:21 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 1,100 | $68.68 | $75,545.80 |
DisclosureSEC source: 0001437749-24-007457 · rdgdoc.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,561 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $68.52 to $68.92. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 20:21 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 3,442 | $68.02 | $234,138.61 |
DisclosureSEC source: 0001437749-24-007457 · rdgdoc.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,661 F1 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $67.505 to $68.42. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 01:51 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 3.0084 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-006504 · rdgdoc.xml · derivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.0252 Underlying: Common Stock · 3.0084 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · shares: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 01:51 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 86 | $70.00 | $6,020.00 |
DisclosureSEC source: 0001437749-24-006504 · rdgdoc.xml · nonDerivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,103 F4 · shares: These shares represent shares withheld by the issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on December 12, 2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.